According to the recent research report titled ‘Venous Thromboembolism Treatment Market Size By Device (Compression System, Thrombectomy Systems, IVC Filters, Stockings), By Application (Deep Vein Thrombosis, Pulmonary Embolism), By End-use (Hospitals, Catheterization Laboratories), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2021 – 2027’, available with Market Study Report, global venous thromboembolism treatment market is anticipated to grow substantially over 2021-2027.
 

Increasing incidences of cancer, rising pervasiveness of pulmonary embolism, growing number of orthopedic surgeries, and improving availability of mechanical therapy products are the key factors driving global venous thromboembolism treatment market growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3793266/
 

For those uninitiated, blood clots or a blood clot in the veins are referred to as venous thromboembolism. It is a dangerous and underdiagnosed medical illness that is avoidable and can result in death or disability. After stroke and heart attack, VTE is the third most common vascular diagnosis, affecting roughly 300,000 to 600,000 Americans each year.
 

Hospitalization, immobility, surgery, and cancer are the most common triggers of VTE. For the treatment of VTE, the most common choices are thrombolytic and anticoagulant medication.
 

Based on device, stockings segment is expected to register 7.8% CAGR over 2021-2027, owing to growing product adoption on account of better outcomes like enhanced blood flow, and reduced swelling and pain.
 

Elaborating on application spectrum, global venous thromboembolism treatment market from deep vein thrombosis segment accrued USD 530 million in 2020 and is likely to grow further, attributable to rising pervasiveness of obesity and cancer, and booming elderly population.
 

DVT is a blood clot that forms in a deep vein, usually in the leg and can sometimes affect the arm or other veins. It commonly develops in the legs when the blood flow is disrupted or slowed. To be more specific, the use of hormones like estrogen or oral contraceptives for menopause symptoms or pregnancy in women could possibly play a role.
 

Moving on to end use scope, catheterization laboratories segment is anticipated to record 9.7% CAGR over the analysis period, creditable to increased number of patients in cath labs and surging demand for improved medication.
 

Regionally, U.S. venous thromboembolism treatment industry amassed USD 380 million in 2020 and is projected to expand significantly by the year 2027, owing to growing adoption of advanced products, substantial number of sophisticated cath labs, and presence of major players in the region.
 

Top companies influencing global venous thromboembolism treatment market trends are Argon Medical Devices, Cook Medical Gorup, Daesung Maref Co. Ltd., Covidien (Medtronic plc), Cardinal Health Inc., AngioDynamics Inc., and Boston Scientific Corporation.